Knockout of SHP-1 in CD133 chimeric antigen receptor (CAR) T-cells significantly enhanced the cytolytic effect on CD133+ glioma cell lines by CAR T-cells and increased secretion of TNF-α, IL-2 and IFN-γ [122]. The gene discussed is PROM1; the disease is glioma.